Warning: mysqli_query(): (HY000/1030): Got error 28 from storage engine in /home/mmahotstuff3/public_html/wp-includes/wp-db.php on line 1924
Ardelyx, Inc. (ARDX) EPS Estimated At $-0.38 - Money Making Articles Hot Stuff

Ardelyx, Inc. (ARDX) EPS Estimated At $-0.38

October 13, 2018 - By Winifred Garcia

Ardelyx, Inc. (NASDAQ:ARDX) Logo

Analysts expect Ardelyx, Inc. (NASDAQ:ARDX) to report $-0.38 EPS on November, 6.They anticipate $0.06 EPS change or 13.64 % from last quarter’s $-0.44 EPS. After having $-0.42 EPS previously, Ardelyx, Inc.’s analysts see -9.52 % EPS growth. The stock decreased 1.33% or $0.05 during the last trading session, reaching $3.7. About 311,656 shares traded. Ardelyx, Inc. (NASDAQ:ARDX) has declined 28.97% since October 13, 2017 and is downtrending. It has underperformed by 44.59% the S&P500.

Ardelyx, Inc. (NASDAQ:ARDX) Ratings Coverage

Among 2 analysts covering Ardelyx (NASDAQ:ARDX), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Ardelyx had 2 analyst reports since August 9, 2018 according to SRatingsIntel. On Thursday, August 9 the stock rating was maintained by Citigroup with “Buy”.

Ardelyx, Inc. develops and sells therapeutics for the treatment of cardio renal and gastrointestinal diseases in the United States. The company has market cap of $229.60 million. The Company’s lead product candidate is tenapanor, which is in Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It currently has negative earnings. The firm is also developing RDX7675, which is in Phase III clinical trial for the treatment of people with hyperkalemia; and RDX8940 in Phase I clinical trial for the treatment of patients with NASH and other gastrointestinal indications.

Another recent and important Ardelyx, Inc. (NASDAQ:ARDX) news was published by Seekingalpha.com which published an article titled: “Key events next week – healthcare” on October 05, 2018.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:



Warning: mysqli_query(): (HY000/1030): Got error 28 from storage engine in /home/mmahotstuff3/public_html/wp-includes/wp-db.php on line 1924
>